US Patent 7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes

Patent 7101898 was granted and assigned to Novo Nordisk on September, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Bernd Peschke0

Ingrid Pettersson0

Edits on 31 Aug, 2023

"Add patent abstract"

Golden AI

edited on 31 Aug, 2023

Edits made to:

Article (+578 characters)

Article

Patent abstract

Novel amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes, use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds, and a method of treatment employing these compounds and compositions. The compounds show a high and selective binding affinity to the histamine H3 receptor indicating histamine H3 receptor antagonistic, inverse agonistic or agonistic activity. As a result, the compounds are useful for the treatment of diseases and disorders related to the histamine H3 receptor.

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071018980

Edits on 20 May, 2023

"Remove leading 0 from patent number"

Golden AI